View Cart (0 items)
No common thread found in string of patient infections at Alabama dialysis clinic
Investigators have been unable to find a common thread between two patient deaths and five hospitalizations at a Fresenius dialysis clinic in in Bessemer, Ala.
NRAA sends letter to CMS addressing price increase of Amgen's Epogen
Price increase adds to potential financial strain on dialysis clinics caused by rebasing of the ESRD bundle
CMS: Health plans for dialysis patients on Medicare Advantage not impacted by sequester
Payers for dialysis patients on Medicare Part D or on Medicare Advantage are not being impacted by the sequestor, CMS said last month.

Amgen increases price of anemia drug for dialysis patients
Amgen Inc. has increased the price of Epogen, its anemia drug for dialysis patients, by 5%, the first price change for the drug since 2011

WHAT'S NEW

Blogs

Dialysis Outcomes Practice Pattern Study shows EPO dose, Hbs continue descent

With the shadow of rebasing hanging over the ESRD payment bundle in 2013, dialysis providers are hunkering down on preparing for the worst. That includes shedding more and more units of the once-profitable anemia drug Epogen––and bringing hemoglobins down with it. More

National Kidney Foundation address: Working together key to improving dialysis quality

Improving quality outcomes in the dialysis setting requires multidisciplinary teamwork, said incoming National Kidney Foundation president Beth Piraino during her address at the foundation's annual meeting. More

COMMUNITY

Stay Connected

NN&I eNews is published three times a week and delivers news concerning renal policy, business, and clinical news. The NN&I NewsWire brings the latest insights from conferences, meetings, and symposia straight to your inbox. QIP, The Newsletter is a monthly newsletter that helps the renal community understand the effects of the ESRD Quality Incentive Program.

  twitterlarge1.png  rsslarge1.png

Our Expertise

Nephrology News & Issues published its first issue in 1987 with the aim of informing readers of the latest developments in nephrology while providing a forum for the exchange of ideas among the professional disciplines responsible for delivering care to the end-stage renal disease patient.